Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

<p>Abstract</p> <p>Background</p> <p>Estrogen receptor positive (ER+) breast cancers (BC) are heterogeneous with regard to their clinical behavior and response to therapies. The ER is currently the best predictor of response to the anti-estrogen agent tamoxifen, yet up...

Full description

Bibliographic Details
Main Authors: Daidone Maria G, Reid James F, Ellis Paul, Ryder Kenneth, Gillet Cheryl, Tutt Andrew M, Lallemand Françoise, Wirapati Pratyaksha, Desmedt Christine, Haibe-Kains Benjamin, Loi Sherene, Pierotti Marco A, Berns Els MJJ, Jansen Maurice PHM, Foekens John A, Delorenzi Mauro, Bontempi Gianluca, Piccart Martine J, Sotiriou Christos
Format: Article
Language:English
Published: BMC 2008-05-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/9/239

Internet

http://www.biomedcentral.com/1471-2164/9/239

Similar Items